
The immense pressure on pharmaceutical marketers to deliver precise, compliant, and measurable campaigns has reached a critical juncture in a market now valued at over $20 billion. This environment demands more than just incremental improvements; it calls for a fundamental restructuring of how campaigns are planned, executed, and analyzed. The healthcare professional (HCP) advertising landscape is rapidly evolving to meet










